Nisa Investment Advisors, LLC Bridge Bio Pharma, Inc. Transaction History
Nisa Investment Advisors, LLC
- $16.7 Billion
- Q3 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 32,053 shares of BBIO stock, worth $891,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,053
Previous 31,878
0.55%
Holding current value
$891,714
Previous $807,000
1.12%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$703 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$699 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$395 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$346 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$169 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.12B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...